Role of sFlt-1/PlGF ratio and feto-maternal Doppler for the prediction of adverse perinatal outcome in late-onset pre-eclampsia

被引:27
|
作者
Graupner, Oliver [1 ]
Karge, Anne [1 ]
Flechsenhar, Sarah [1 ]
Seiler, Alina [1 ]
Haller, Bernhard [2 ]
Ortiz, Javier U. [1 ]
Lobmaier, Silvia M. [1 ]
Axt-Fliedner, Roland [3 ]
Enzensberger, Christian [3 ]
Abel, Kathrin [1 ]
Kuschel, Bettina [1 ]
机构
[1] Univ Hosp rechts Isar, Syst Univ Munich, Dept Obstet, Gynecology, Ismaninger Str. 22, DE-81675 Munich, Germany
[2] Univ Hosp rechts Isar, Syst Univ Munich,Inst Med Informat,Stat,Epidmiol, IMedIS, Munich, Germany
[3] Univ Hosp UKGM, Liebig Univ,Dept Obstet,Div Prenatal Med, Gynecology,Justus, Giessen, Germany
关键词
Preeclampsia; (anti-) Angiogenic factors; Placental growth factor; Soluble fms-like tyrosine kinase 1; Cerebroplacental ratio; Uterine artery Doppler; FETAL-GROWTH RESTRICTION; UTERINE ARTERY DOPPLER; CEREBROPLACENTAL RATIO; ANGIOGENIC FACTORS; PREGNANCY; WOMEN; RISK; TERM; CLASSIFICATION; DIAGNOSIS;
D O I
10.1007/s00404-019-05365-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose The sFlt-1 (soluble fms-like tyrosine kinase-1)/PlGF (placental growth factor) ratio and uterine artery Doppler have shown to be helpful in the diagnosis of pre-eclampsia (PE). The predictive value of the cerebroplacental ratio (CPR) regarding adverse perinatal outcome (APO) in low-risk pregnancies is intensively discussed. We evaluated the extent to which sFlt-1/PlGF ratio and feto-maternal Doppler may be useful in predicting APO in singleton pregnancies complicated by late-onset PE and/or HELLP syndrome. Methods This is a retrospective study from 2010 to 2018 consisting of singleton pregnancies with confirmed diagnosis of late-onset (lo >= 34 weeks) PE/HELLP syndrome in which sFlt-1/PlGF ratio and feto-maternal Doppler (mUtA-PI: mean uterine artery pulsatility index and CPR) were determined. The ability of sFlt-1/PlGF ratio, mUtA-PI, CPR and their combination to predict APO or SGA was evaluated using receiver operating characteristic (ROC) curves. Results 67 patients were included in the final analysis. Of these, sFlt-1/PlGF was > 110 (defining angiogenic lo PE) in 40.3% (27/67), mUtA-PI was above the 95th centile in 34.3% (23/67) patients and CPR was lower than the 5th centile in 10.4% (7/67). Abnormal sFlt-1/PlGF and mUtA-PI as well as CPR were associated with a lower birth weight (BW). Late-preterm birth (< 37 weeks) as well as postnatal diagnosis of small for gestational age (SGA: BW < 3rd centile) was significantly more often in angiogenic lo PE cases. Neither sFlt-1/PIGF nor CPR or mUtA-PI were APO predictors. Only for sFlt-1/PlGF, ROC analysis revealed a significant predictive value for postnatal SGA (AUC = 0.856, p = 0.001, 95% CI 0.75-0.97). There was no statistical added value of combined SGA predictors as compared to sFlt-1/PlGF alone. Conclusions In patients with lo PE, adding sFlt-1/PlGF ratio to routine antepartum fetal surveillance may be useful to identify cases of postnatal SGA. However, further prospective studies are warranted to define the role of feto-maternal Doppler and sFlt-1/PlGF ratio as outcome predictors.
引用
收藏
页码:375 / 385
页数:11
相关论文
共 50 条
  • [31] Agreement between different PlGF tests and the sFlt-1/PlGF ratio for prediction of pre-eclampsia and potential to predict fetal growth restriction in high risk populations
    Navaratnam, K.
    Agarwal, U.
    Alfirevic, Z.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 : 46 - 46
  • [32] Rule-in and rule-out of pre-eclampsia using DELFIA Xpress PlGF 1-2-3 and sFlt-1: PlGF ratio
    Bremner, Laura
    Gill, Carolyn
    Seed, Paul T.
    Conti-Ramsden, Frances
    Webster, Louise
    Fleminger, Jessica
    Chappell, Lucy C.
    Shennan, Andrew
    Bramham, Kate
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2022, 27 : 96 - 102
  • [33] Clinical Utility of sFlt-1 and PlGF in Screening, Prediction, Diagnosis and Monitoring of Pre-eclampsia and Fetal Growth Restriction Comment
    Stepan, H.
    Galindo, A.
    Hund, M.
    Schlembach, D.
    Sillman, J.
    Surbek, D.
    Vatish, M.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2023, 78 (08) : 451 - 453
  • [34] Role of sFlt-1/PIGF ratio and uterine Doppler in pregnancies with chronic kidney disease suspected with Pre-eclampsia or HELLP syndrome
    Karge, Anne
    Beckert, Lina
    Moog, Philipp
    Haller, Bernhard
    Ortiz, Javier U.
    Lobmaier, Silvia M.
    Abel, Kathrin
    Flechsenhar, Sarah
    Kuschel, Bettina
    Graupner, Oliver
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2020, 22 : 160 - 166
  • [35] Prediction of Adverse Pregnancy Outcome Related to Placental Dysfunction Using the sFlt-1/PlGF Ratio: A Narrative Review
    Graupner, Oliver
    Enzensberger, Christian
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (08) : 948 - 954
  • [36] Significance of the sFlt-1/PIGF Ratio and the uterine Doppler for the Prediction of the perinatal and maternal Outcome in Pregnant Women with chronic Kidney Disease
    Karge, A.
    Beckert, L.
    Moog, P.
    Haller, B.
    Ortiz, J.
    Abel, K.
    Lobmaier, S.
    Kuschel, B.
    Graupner, O.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E126 - E126
  • [37] SFLT-1/PLGF Ratio, in Pregnancies Complicated by Hypertensive Disorder and/or Fetal Growth Restriction, for Prediction of Maternal and Perinatal Complications
    Sabattini, Elisa
    Giardini, Valentina
    Tine, Gabriele
    Sterpi, Vittoria
    Zaccone, Elena
    Acampora, Eleonora
    Radaelli, Tatjana
    Ossola, Manuela Wally
    Stampalija, Tamara
    Vergani, Patrizia
    Ferrazzi, Enrico
    Di Martino, Daniela
    REPRODUCTIVE SCIENCES, 2022, 29 (SUPPL 1) : 171 - 171
  • [38] Implementation of the sFlt-1/PIGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice
    Stepan, H.
    Herraiz, I.
    Schlembach, D.
    Verlohren, S.
    Brennecke, S.
    Chantraine, F.
    Klein, E.
    Lapaire, O.
    Llurba, E.
    Ramoni, A.
    Vatish, M.
    Wertaschnigg, D.
    Galindo, A.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2015, 45 (03) : 241 - 246
  • [39] The sFLT-1/PlGF Ratio for the Prediction of Preeclampsia-Related Adverse Fetal and Maternal Outcomes in Women with Preexisting Diabetes
    Provendier, Anais
    Migliorelli, Federico
    Loussert, Lola
    Boileau, Beatrice Guyard
    Vayssiere, Christophe
    Hamdi, Safouane M.
    Hanaire, Helene
    Dupuis, Ninon
    Guerby, Paul
    REPRODUCTIVE SCIENCES, 2024, 31 (08) : 2371 - 2378
  • [40] Screening for pre-eclampsia using sFlt-1/PlGF ratio cut-off of 38 at 30-37 weeks' gestation
    Dragan, I.
    Georgiou, T.
    Prodan, N.
    Akolekar, R.
    Nicolaides, K. H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2017, 49 (01) : 73 - 77